Neurim Pharmaceuticals will market its new drugs through strategic alliances with reputable marketing and distribution partners on whose marketing expertise we are rely.

Neurim is currently targeting mainly the European, North American and Japanese markets.

Neurim has so far established marketing and sales agreements with LUNDBECK, and NYCOMED :

We are actively seeking strategic alliances for non-European markets.

 Please feel free to contact us:

Eran Schenker  MD
Director, Corporate Business Development 
Neurim Pharmaceuticals Ltd.
8 Hanechoshet St Tel-Aviv 69710 Israel
EranS@Neurim.com